Invivyd logo

Invivyd Employee Directory

Biotechnology ResearchConnecticut, United States51-200 Employees

Invivyd is a biotechnology company based in New Haven, Connecticut, focused on developing antibody-based medicines designed to be highly potent and more resilient to viral evolution than the human immune system. The company uses a proprietary, integrated technology platform to guide the discovery, development, monitoring, and adaptation of antibodies, aiming to deliver preventive therapies with strong protective potential. Operating as a mid-sized organization, it concentrates on monoclonal antibodies within the biotechnology research sector.

Its work centers on preventing COVID-19 with antibody therapies, offering a vaccine-alternative option and exploring co-administration with vaccines in clinical trials. In June 2026, the company announced that the LIBERTY Phase 3 trial began dosing participants to evaluate the antibody alone, the vaccine alone, and their combination.

Find Invivyd employees' phone numbers or email addresses

Invivyd Global Highlights

Location
Employees

North America
183

Minus sign iconPlus sign icon
  • United States Of America
    183

Invivyd's Leadership

  • Chief Legal Officer And Corporate Secretary at Invivyd
    J. A.
    Chief Legal Officer And Corporate Secretary
  • Head Of Commercial Operations at Invivyd
    J. L.
    Head Of Commercial Operations
  • Associate Director, Drug Safety And Pharmacovigilance at Invivyd
    A. S.
    Associate Director, Drug Safety And Pharmacovigilance
  • Associate Director, Field Force Effectiveness And Data Management at Invivyd
    C. P.
    Associate Director, Field Force Effectiveness And Data Management
  • Associate Director, Drug Product Manufacturing at Invivyd
    W. S.
    Associate Director, Drug Product Manufacturing
  • Associate Director, Program Management at Invivyd
    R. S.
    Associate Director, Program Management
  • Strategic Account Manager at Invivyd
    J. K.
    Strategic Account Manager
  • Strategic Account Manager at Invivyd
    M. F.
    Strategic Account Manager

Invivyd Employee Metrics

100%
50%
0%
2026
2025
  • Sales
  • Biotechnology
  • Legal
  • Accounting
  • Administrative
  • Other
  • Community & Social Services

Contact profiles from Invivyd

Name
Title
Contact
Location
Last Update
  • Strategic Account Manager at Invivyd
    L. R. R.
    Strategic Account Manager
    Jun 29, 2026
  • Field Reimbursement Manager at Invivyd
    R. J.
    Field Reimbursement Manager
    Jun 28, 2026
  • Senior Manager, Scientific Writing at Invivyd
    S. J.
    Senior Manager, Scientific Writing
    Jul 14, 2026

Frequently Asked Questions

What is Invivyd known for?

Minus sign iconPlus sign icon
Invivyd was founded in 2020 and operates in the Biotechnology Research industry. Explore Invivyd's company overview page for more information.

What is Invivyd's most common email format?

Minus sign iconPlus sign icon
Invivyd employees' email format typically follows the pattern of First.Last@adagiotx.com. Trying to find reliable and up-to-date employee contact data? Find more Invivyd email formats with LeadIQ.

How many employees does Invivyd have currently?

Minus sign iconPlus sign icon
Invivyd has approximately 189 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are Invivyd's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Invivyd's key employees include:

  • Chief Legal Officer And Corporate Secretary: J. A.
  • Head Of Commercial Operations: J. L.
  • Associate Director, Drug Safety And Pharmacovigilance: A. S.
  • Associate Director, Field Force Effectiveness And Data Management: C. P.
  • Associate Director, Drug Product Manufacturing: W. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.